Elisa Scarselli
Elisa Scarselli is the Chief Scientific Officer of Nouscom, a biopharmaceutical company focused on developing innovative cancer immunotherapies. She has played a key role in advancing the NOUS-209 vaccine, which has shown promising results in preventing cancer for individuals at high risk due to Lynch syndrome.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Dominican Republic:
Elisa Scarselli is the scientific director of Nouscom who highlighted the potential of NOUS-209.
9